- NHL Treatment
- Hodgkin's Treatment
- Clinical Trials
- Monoclonal Antibodies
It is the second most commonly diagnosed B-cell non-Hodgkin's lymphoma, after diffuse large B-cell lymphoma. FL is regarded as a manageable disease that may or may not require treatment. Although manageable, FL is not considered curable.
Follicular lymphoma is rarely a fatal disease; patients are far more likely to survive their lymphoma than succumb to it. However, FL can sometimes progress into a more aggressive form of lymphoma that will require more aggressive treatment.
In an effort to give patients and doctors alike a better idea of the prognosis of any one FL patient, a prognostic index was developed known as the Follicular Lymphoma International Prognostic Index (FLIPI).
Since first being introduced several years ago, the FLIPI risk groups and overall lymphoma survival rates have been validated by subsequent studies. However, it does have its limitations, and really should only be used by patients and doctors together in improving the treatment choices they make.